NCT04743245View on ClinicalTrials.gov

Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.

NARecruitingINTERVENTIONAL
Enrollment

434

Participants

Timeline

Start Date

August 2, 2022

Primary Completion Date

October 31, 2025

Study Completion Date

April 30, 2026

Conditions
Acute Myocardial InfarctionSTEMI
Interventions
DEVICE

TherOx DownStream System

SSO2 Therapy with Therox downstream System after Percutaneous Coronary Intervention (PCI)

DEVICE

PCI

Standard Care of PCI

Trial Locations (1)

01199

RECRUITING

Baystate Medical Center, Springfield

Sponsors

Lead Sponsor

TherOx
All Listed Sponsors
lead

TherOx

INDUSTRY

NCT04743245 - Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard. | Biotech Hunter | Biotech Hunter